• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article 

    Google Scholar
     

  • Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;2:1158.


    Google Scholar
     

  • Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21(8):67.

    Article 

    Google Scholar
     

  • Akbari A, Ashtari S, Tabaiean SP, Mehrdad-Majd H, Farsi F, Shojaee S, et al. Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia-Pacific region. Asia-Pacific J Clin Oncol. 2022;2:558.


    Google Scholar
     

  • Ryu JE, Choi E, Lee K, Jun JK, Suh M, Jung KW, et al. Trends in the performance of the Korean National cancer screening program for gastric cancer from 2007 to 2016. Cancer Res Treat. 2021;5:117.


    Google Scholar
     

  • Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–90.

    Article 

    Google Scholar
     

  • Yang X, Zhang T, Zhang H, Sang S, Chen H, Zuo X. Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia. Biomarker Res. 2021;9(1):84.

    Article 

    Google Scholar
     

  • Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783–91.

    Article 

    Google Scholar
     

  • Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang Y, et al. A global burden of gastric cancer: the major impact of China. Expert Rev Gastroenterol Hepatol. 2017;11(7):651–61.

    CAS 
    Article 

    Google Scholar
     

  • He Y, Wang Y, Luan F, Yu Z, Feng H, Chen B, et al. Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med. 2021;10(10):3461–73.

    Article 

    Google Scholar
     

  • Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–42.

    Article 

    Google Scholar
     

  • Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer. 2018;21(1):144–54.

    Article 

    Google Scholar
     

  • D’Ugo D, Agnes A, Grieco M, Biondi A, Persiani R. Global updates in the treatment of gastric cancer: a systematic review. Part 2: perioperative management, multimodal therapies, new technologies, standardization of the surgical treatment and educational aspects. Updates Surg. 2020;72(2):355–78.

    Article 

    Google Scholar
     

  • Ono H, Yao K, Fujishiro M, Oda I, Uedo N, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2021;33(1):4–20.

    Article 

    Google Scholar
     

  • Ji L, Liu Z, Zhou B, Cai Y, An F, Wang L, et al. Community-based pilot study of a screening program for gastric cancer in a Chinese population. Cancer Prev Res (Phila). 2020;13(1):73–82.

    Article 

    Google Scholar
     

  • Mabe K, Inoue K, Kamada T, Kato K, Kato M, Haruma K. Endoscopic screening for gastric cancer in Japan: current status and future perspectives. Dig Endosc. 2022;34(3):412–9.

    Article 

    Google Scholar
     

  • Noh CK, Lee E, Lee GH, Lim SG, Park B, Shin SJ, et al. Association of regular endoscopic screening with interval gastric cancer incidence in the National Cancer Screening Program. J Clin Med. 2021;11(1):1145.

    Article 

    Google Scholar
     

  • Komatsu S, Otsuji E. Essential updates 2017/2018: recent topics in the treatment and research of gastric cancer in Japan. Ann Gastroenterol Surg. 2019;3(6):581–91.

    Article 

    Google Scholar
     

  • Ascherman B, Oh A, Hur C. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk. Gastric Cancer. 2021;24(4):878–87.

    Article 

    Google Scholar
     

  • Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, et al. Screening for gastric cancer in China: advances, challenges and visions. Chin J Cancer Res. 2021;33(2):168–80.

    CAS 
    Article 

    Google Scholar
     

  • Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–87.

    CAS 
    Article 

    Google Scholar
     

  • Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, et al. Gastric cancer: Epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32:695–704.

    CAS 
    Article 

    Google Scholar
     

  • Hatamian S, Etesam S, Mazidimoradi A, Momenimovahed Z, Salehiniya H. The barriers and facilitators of gastric cancer screening: a systematic review. J Gastrointest Cancer. 2021;52(3):839–45.

    Article 

    Google Scholar
     

  • Furihata C. Human gastric cancer risk screening: from rat pepsinogen studies to the ABC method. Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(8):462–78.

    CAS 
    Article 

    Google Scholar
     

  • Zhu J, Wang SM, Chen R, Li XQ, Wei WW. Progress on screening for gastric cancer. Zhonghua Zhong Liu Za Zhi. 2020;42(7):603–8.

    CAS 
    PubMed 

    Google Scholar
     

  • Liu XM, Ma XY, Liu F, Liu ZL, Tang XY, Ji MZ, et al. Gastric cancer screening methods: a comparative study of the Chinese new gastric cancer screening score and Kyoto classification of gastritis. Gastroenterol Res Pract. 2022;2022:7639968.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, et al. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. Am J Gastroenterol. 2017;112(5):704–15.

    Article 

    Google Scholar
     

  • Wang Y, Zhu Z, Liu Z, Zhao Z, Xue X, Li X, et al. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer. J Int Med Res. 2020;48(3):300060520914826.

    CAS 
    PubMed 

    Google Scholar
     

  • Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, et al. Gastric cancer screening by combined assay for serum anti-helicobacter pylori IgG antibody and serum pepsinogen levels-the ABC method. Digestion. 2016;93(1):13–8.

    CAS 
    Article 

    Google Scholar
     

  • Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-“ABC method”. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405–14.

    Article 

    Google Scholar
     

  • Kishino T, Oyama T, Tomori A, Takahashi A, Shinohara T. Usefulness and limitations of a serum screening system to predict the risk of gastric cancer. Internal Med (Tokyo, Japan). 2020;59(12):1473–80.

    CAS 
    Article 

    Google Scholar
     

  • Shimoyama T, Aoki M, Sasaki Y, Matsuzaka M, Nakaji S, Fukuda S. ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis. Gastric Cancer. 2012;15(3):331–4.

    Article 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)